Blogs

Stay current with product and data science updates, industry and technology trends, and culture updates from the CancerLinQ team.

Impact of COVID-19 Disease on Oncology Practice: Targeted Therapies Used in Lung Cancer

COVID-19 Surveillance Report
Trends in prescription and/or administration of targeted therapies used in lung cancer by month since January 2019

Impact of COVID-19 Disease on Oncology Practice: Aromatase inhibitors and tamoxifen

CancerLinQ Data
Trends in prescription and/or administration of aromatase inhibitors and tamoxifen by month since January 2019

Impact of COVID-19 Disease on Oncology Practice: Chemotherapy Drug for Breast, Colon and Lung Cancer

COVID-19 Surveillance Report
This is the second in a series of reports on the impacts of COVID-19 disease on the practice of oncology as observed through de-identified CancerLinQ…

Update on demographic data on COVID-19 patients in CancerLinQ

CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients

View Recent COVID-19 Demographics

CancerLinQ Data
CancerLinQ is monitoring COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients.

Observations on the Impact of COVID Disease on Oncology Practice from CancerLinQ: Telemedicine Encounters and Immune Checkpoint Inhibitors

COVID-19 Surveillance Report
Every day, the news has new reports of changes in the delivery of health care. At CancerLinQ, a learning health system developed by the American…